INDUSTRY SECTOR

PHARMACEUTICALS & HEALTH

Economic analysis is essential in addressing the role of competitive markets in the provision of health services and the merits of alternative regulatory regimes.

Europe Economics is able to provide consulting services on a range of regulatory and strategic issues in the pharmaceutical and health sectors. Areas of expertise include the following:

Public policy analysis.  The firm can advise on the optimal methods of regulation and reimbursement for pharmaceuticals; on policies for increasing world markets and access to medicines; and on EU single market policy issues.

Regulatory issues.  Europe Economics is expert in all aspects of economic regulation.

Litigation support.  The firm advises on damage estimation, using robust and sophisticated economic techniques; on intellectual property and packaging issues; and on competition cases.

Business strategy.  The firm can advise on the implications for business strategy of developments in government healthcare policies, of current developments in information flows that are likely to transform the ways pharmaceutical markets work, and on forms of contract.

Europe Economics has carried out consulting assignments in pharmaceutical and health areas for public sector bodies, major pharmaceutical companies and industry associations.  The firm has experience in working for clients in the UK, other European countries, Africa and the United States. Recent projects include a report and technical model on reform of reimbursement regulation for the Portuguese pharmaceuticals regulator, INFARMED; litigation support for Ranbaxy in the Penicillins and Ranitidine Proceedings in the UK; and work for the European Commission (DG Enterprise and Industry) on the impacts of policies towards excipients.